Medications

Developing drugs to help fight Rift Valley fever virus

Research by Lawrence Livermore National Laboratory (LLNL) scientists suggests that immune responses could be bolstered by drugs to help people recover from brain infections caused by an emerging pathogen.

Diseases, Conditions, Syndromes

Arizona economic burden of valley fever totals $736 million

A University of Arizona Health Sciences study has estimated total lifetime costs at $736 million for the 10,359 valley fever patients diagnosed in Arizona in 2019, underscoring the economic burden the disease places on the ...

page 4 from 14